Your browser doesn't support javascript.
loading
DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells.
Camponeschi, Alessandro; Todi, Laura; Cristofoletti, Cristina; Lazzeri, Cristina; Carbonari, Maurizio; Mitrevski, Milica; Marrapodi, Ramona; Del Padre, Martina; Fiorilli, Massimo; Casato, Milvia; Visentini, Marcella.
Afiliação
  • Camponeschi A; Department of Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg Sweden.
  • Todi L; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Cristofoletti C; Molecular Oncology, IDI-IRCCS, Rome, Italy.
  • Lazzeri C; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Carbonari M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Mitrevski M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Marrapodi R; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Del Padre M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
  • Fiorilli M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Casato M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy.
  • Visentini M; Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: marcella.visentini@uniroma1.it.
Immunol Lett ; 198: 7-11, 2018 06.
Article em En | MEDLINE | ID: mdl-29601939
ABSTRACT
The transcription factor DEC1/STRA13 (also known as BHLHE40 and SHARP2) is involved in a number of processes including inhibition of cell proliferation and delay of cell cycle, and is a negative regulator of B cell activation and development in mice. We show here that, unlike in mice, DEC1/STRA13 expression is induced in human naïve and memory resting B cells by activation through the B-cell receptor (BCR) or Toll-like receptor 9 (TLR9). siRNA silencing of DEC1/STRA13 increases the capacity of activated B cells to perform a high number of divisions after TLR9 ligation. This identifies DEC1/STRA13 as a critical negative regulator of clonal expansion of activated human B cells. We also show that DEC1/STRA13 is upregulated in human anergic CD21low B cells clonally expanded in patients with HCV-associated mixed cryoglobulinemia, which fail to proliferate in response to BCR or TLR9 ligation. siRNA knockdown of DEC1/STRA13, however, fails to restore responsiveness to stimuli in these cells, although it might improve the proliferative capacity in a subset of anergic cells with less pronounced proliferative defect.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária / Anergia Clonal / Proteínas de Homeodomínio / Fatores de Transcrição Hélice-Alça-Hélice Básicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunol Lett Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Ativação Linfocitária / Anergia Clonal / Proteínas de Homeodomínio / Fatores de Transcrição Hélice-Alça-Hélice Básicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Immunol Lett Ano de publicação: 2018 Tipo de documento: Article